| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/12/2002 | EP0873362B1 PROCESS FOR ISOLATING IgG AND IgA |
| 06/12/2002 | EP0873320B1 Piperazine derivatives as tachykinin antagonists |
| 06/12/2002 | EP0873312B1 Alpha-substituted arylsulphonamido hydroxamic acids as tnf-alpha and matrix metalloproteinase inhibitors |
| 06/12/2002 | EP0873122B1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of prostatic carcinoma |
| 06/12/2002 | EP0867185B1 Platelet function potentiator and method of curing platelet dysfunction |
| 06/12/2002 | EP0859621B1 Biocompatible aqueous solution for use in continuous ambulatory peritoneal dialysis |
| 06/12/2002 | EP0855913B1 Iron dextran formulations |
| 06/12/2002 | EP0852467B1 Cancer chemoprotective food products |
| 06/12/2002 | EP0841933B1 Bowman-Birk inhibitor compositions for treatment of inflammatory disease |
| 06/12/2002 | EP0825857B1 Use of gabapentin and its derivatives in the treatment of mania and bipolar disorder |
| 06/12/2002 | EP0814791B1 Aminotetralin derivative for the therapy of cardiovascular diseases |
| 06/12/2002 | EP0813407B1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 06/12/2002 | EP0808314B1 Forms of paroxetin hydrochloride |
| 06/12/2002 | EP0807185B1 Antitumor preparations containing a lipoteichoic acid from steptococcus |
| 06/12/2002 | EP0805684B1 Methods of enhancing the therapeutic activity of nsaids and compositions of zwitterionic phospholipids useful therein |
| 06/12/2002 | EP0776324B1 Endothelin antagonists |
| 06/12/2002 | EP0772603B1 Substituted pyrimidine compounds and their use |
| 06/12/2002 | EP0768881B1 Anti-hiv triple combination comprising zidovudine, lamivudine and loviride |
| 06/12/2002 | EP0759774B1 Method of treating gram-negative bacterial infection by administration of bactericidal/permeability-increasing (bpi) protein product and antibiotic |
| 06/12/2002 | EP0751939B1 Naphthylamides as central nervous system agents |
| 06/12/2002 | EP0737200B1 Biologically active silicon compounds and their therapeutic and cosmetic applications |
| 06/12/2002 | EP0734391B1 Pna-dna-pna chimeric macromolecules |
| 06/12/2002 | EP0734259B1 Use of piperidine compounds in the treatment of schizophrenia |
| 06/12/2002 | EP0730460B1 The use of an ester of inositoltrisphosphate for the treatment of inflammatory conditions |
| 06/12/2002 | EP0717625B1 A method of treating liver disease and like indications with vasodilating agents |
| 06/12/2002 | EP0689427B1 Water dispersible therapeutic carotenoid compounds |
| 06/12/2002 | EP0688212B1 C9 taxane derivatives and pharmaceutical compositions containing them |
| 06/12/2002 | EP0688211B1 Thalidomide for inhibition of angiogenesis |
| 06/12/2002 | EP0666753B9 Use of peptides FOR THE TREATMENT OF THE COMPLICATIONS AND PATHOLOGY OF DIABETES |
| 06/12/2002 | EP0652867B1 Novel pyridyl- and pyrimidylpiperazine derivatives |
| 06/12/2002 | EP0625982B1 4-oxo- and 4h-imidazo(5,1-c)(1,4)benzoxazines useful as benzodiazepine receptor-binding agents |
| 06/12/2002 | CN1353735A Silicone gel containing salicylic acid |
| 06/12/2002 | CN1353714A Triazolopyrimidinol compounds and salts thereof |
| 06/12/2002 | CN1353713A Purine inhibitors of cyclin dependent kinase 2 and IK B-alpha |
| 06/12/2002 | CN1353712A Polymorphs of crystalline (2-benzhydryl-2-azabicyclo [2.2.2] OCT-3-yl)-(5-isopropyl-2-methoxybenzyl)-amine citrate as NK-1 receptor antagonists |
| 06/12/2002 | CN1353711A Polymorphs of crystalline azabicyclo (2,2,2) octan-3-amine citrate and their pharmaceutical compositions |
| 06/12/2002 | CN1353710A 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof |
| 06/12/2002 | CN1353709A Bicyclic oxazolidinones as antibacterial agents |
| 06/12/2002 | CN1353708A Pyrrolidinyl, piperidinyl or homopiperidinyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 06/12/2002 | CN1353707A aminoalkyl substituted (benzodioxan, benzofuran or benzopyran) derivatives |
| 06/12/2002 | CN1353706A Integrin receptor ligands |
| 06/12/2002 | CN1353705A Pyrazinone thrombin inhibitors |
| 06/12/2002 | CN1353704A 取代吡唑化合物 A substituted pyrazole compound |
| 06/12/2002 | CN1353703A tricyclic fused heterocycle compounds, process for preparing the same and use thereof |
| 06/12/2002 | CN1353702A Adamantane derivatives |
| 06/12/2002 | CN1353699A Substituted bicyclic heterocycles, process for their preparation and their use as antiobesity and hypocholesterolemic agents |
| 06/12/2002 | CN1353698A Novel morpholine derivatives, method for production thereof and pharmaceutical preparations containing said derivatives |
| 06/12/2002 | CN1353697A 4-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353696A 5-phenyl-pyrimidine derivatives |
| 06/12/2002 | CN1353695A Heterocyclically substituted benzimidazoles, production and application thereof |
| 06/12/2002 | CN1353694A Alpha-substituted carboxylic acid derivatives |
| 06/12/2002 | CN1353693A Substituted phenylcyclohexane carboxylic acid amides and their use as adenosine uptake inhibitors |
| 06/12/2002 | CN1353692A Betz 2-adrenoceptor agonists |
| 06/12/2002 | CN1353691A Cell adhesion-inhibiting anti inflammatory and immune-suppresive compounds |
| 06/12/2002 | CN1353690A Bradykinin receptor antagonists |
| 06/12/2002 | CN1353689A 新的异羟肟酸衍生物 The new hydroxamic acid derivatives |
| 06/12/2002 | CN1353688A Compounds derived from benzoic acid esters, composition comtaining said compounds and use thereof |
| 06/12/2002 | CN1353687A High purity (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo [2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof |
| 06/12/2002 | CN1353686A Process for preparing (1R,2S,4R)-(-)-2-[(2'-{N,N-dimethylamino}-ethoxy)]-2-[phenyl]-1,7,7-tri-[methyl]-bicyclo[2.2.1] heptane and pharmaceutically acceptable acid addition salts thereof |
| 06/12/2002 | CN1353684A Ether compounds, compositions, and uses thereof |
| 06/12/2002 | CN1353617A Treatment of infertility |
| 06/12/2002 | CN1353610A Medicinal composition for oral administration |
| 06/12/2002 | CN1353609A Amide substituted imidazoquinolines |
| 06/12/2002 | CN1353608A Use of macrolide compounds for treatment of dry eye |
| 06/12/2002 | CN1353607A Improved pharmaceutical formulations |
| 06/12/2002 | CN1353606A IL-8 receptor antagonists |
| 06/12/2002 | CN1353605A Aryl substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles, and use thereof |
| 06/12/2002 | CN1353604A New use of modafinil and D/L enantiomer |
| 06/12/2002 | CN1353603A Method of controlling weight gain associated with therapeutic drugs |
| 06/12/2002 | CN1353574A Disinfecting composition based on H2O2 acids and metal ions |
| 06/12/2002 | CN1353573A Anti-inflammatory therapy for inflammatory mediated infection |
| 06/12/2002 | CN1353183A Establishing recombinant strain of BCG vaccine and its application |
| 06/12/2002 | CN1353113A Active component of achyranthes root, its preparation and medical usage and its preparing process |
| 06/12/2002 | CN1353104A Process for preparing nutritive oil of conjugated diene-linoleic acid from soybean oil |
| 06/12/2002 | CN1353003A Process for screening active component from plant extract |
| 06/12/2002 | CN1352956A Chinese-medicinal spray for treating chronic pharyngolaryngitis and its preparing process |
| 06/12/2002 | CN1352947A Mamma-repairing chitin liquid |
| 06/12/2002 | CN1352946A Nutrient 'Lingguyiyuan' and its preparing process |
| 06/12/2002 | CN1352945A Adenosine as anti-thrombosis medicine |
| 06/12/2002 | CN1352944A Jixitabin solution preparation |
| 06/12/2002 | CN1352943A Medicine for treating disease of motor neuron |
| 06/12/2002 | CN1352942A Medicine for treating tuberculosis |
| 06/12/2002 | CN1352941A 亚油酸胶囊 Linoleic acid capsules |
| 06/12/2002 | CN1352940A Licopin linoleate capsule |
| 06/12/2002 | CN1352939A lycopene capsule |
| 06/12/2002 | CN1352938A Slowly releasing bupropion hydrochloride tablet |
| 06/12/2002 | CN1352896A Process for extracting genistein as anticancer and oncogenic dioxanin resistant substance from fermented soybean |
| 06/12/2002 | CN1086188C Novel phenanethridinium derivatives |
| 06/12/2002 | CN1086126C Prednelan composition for treating rheumatism |
| 06/12/2002 | CN1086125C Externally used medicine for treating tinea |
| 06/12/2002 | CN1086124C Shuangzuoxing suppository |
| 06/12/2002 | CA2364392A1 Compound |
| 06/11/2002 | US6404779 System and method of disharmonic frequency multiplexing |
| 06/11/2002 | US6403831 Substituted benzylidene indenyl formamides, acetamides and propionamides |
| 06/11/2002 | US6403830 Amidino compound and salts thereof useful as nitric oxide synthase inhibitors |
| 06/11/2002 | US6403816 Increased bioavailability and reduced toxicity |
| 06/11/2002 | US6403810 Thiophene derivatives |
| 06/11/2002 | US6403808 Treating mental disorders |
| 06/11/2002 | US6403805 1,3-dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatves |
| 06/11/2002 | US6403799 Methods for the preparation of intermediates in the synthesis of HIV-protease inhibitors |